SILO PHARMA, INC. Receivables, Net, Current
SILO PHARMA, INC. (SILO) had Receivables, Net, Current of $69.60 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2024-03-25
- 2023-09-30: Receivables, Net, Current $69.60K.
- 2023-06-30: Receivables, Net, Current $68.39K.
- 2022-12-31: Receivables, Net, Current $66.01K.
- 2020-12-31: Receivables, Net, Current $23.50K.
| Period end | Receivables, Net, Current |
|---|---|
| 2023-09-30 | $69.60K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $68.39K 10-Q · filed 2023-08-11 |
| 2022-12-31 | $66.01K 10-K · filed 2024-03-25 |
| 2020-12-31 | $23.50K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |